You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 163 No. 14, July 28, 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (54)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Venous Thromboembolism
 •Alert me on articles by topic

Pulmonary Embolism Mortality in the United States, 1979-1998

An Analysis Using Multiple-Cause Mortality Data

Kenneth T. Horlander, MD; David M. Mannino, MD; Kenneth V. Leeper, MD

Arch Intern Med. 2003;163:1711-1717.

Background  Pulmonary thromboembolism (PTE) is a common clinical problem that is associated with substantial morbidity and mortality. Estimates of PTE mortality and predictions of PTE trends have varied widely. These estimates play a role in the planning of national health strategies. The analysis of pulmonary embolism mortality trends and comorbidities may elucidate how well we treat and prevent the disease as well as identify additional risk factors.

Methods  We analyzed PTE (International Classification of Diseases, Ninth Revision code 415.1) as reported on death certificates in the Multiple-Cause Mortality Files compiled by the National Center for Health Statistics from 1979 to 1998.

Results  Of all the 42 932 973 decedents, 572 773 (1.3%) had PTE listed on their death certificates and 194 389 of these (33.9%) had PTE as the underlying cause of death. The age-adjusted rate of deaths with PTE decreased from 191 per million in 1979 to 94 per million in 1998 overall, decreasing 56% for men and 46% for women. During the study period, the age-adjusted mortality rates for blacks were consistently 50% higher than those for whites, and those for whites were 50% higher than those for people of other races (Asian, American Indian, etc). Within racial strata, mortality rates were consistently 20% to 30% higher among men than among women. Conditions that were of higher likelihood in persons who died with PTE included thrombophlebitis, fractures, trauma, postoperative complications, certain cancers, and the inflammatory bowel diseases.

Conclusions  Mortality with PTE in the United States has decreased during the 20-year period. The mortality rates between men and women and between racial groups vary substantially. These findings may be useful in better directing preventive therapy efforts.


From the Division of Pulmonary, Allergy, and Critical Care, Emory University School of Medicine, Atlanta, Ga (Drs Horlander and Leeper); Air Pollution and Respiratory Health Branch, Division of Environmental Hazards and Health Effects, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta (Dr Mannino); and Atlanta Veterans Administration Medical Center (Dr Leeper). Dr Horlander is now with the Department of Pulmonary Medicine, Clark-Holder Clinic, LaGrange, Ga. The authors have no relevant financial interest in this article.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Rosamond et al.
Circulation 2008;117:e25-e146.
FULL TEXT  

Discordance between CT and Angiography in the PIOPED II Study
Wittram et al.
Radiology 2007;244:883-889.
ABSTRACT | FULL TEXT  

How I Do It: CT Pulmonary Angiography
Wittram
Am. J. Roentgenol. 2007;188:1255-1261.
ABSTRACT | FULL TEXT  

Heart Disease and Stroke Statistics--2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Rosamond et al.
Circulation 2007;115:e69-e171.
FULL TEXT  

Twice vs Three Times Daily Heparin Dosing for Thromboembolism Prophylaxis in the General Medical Population: A Metaanalysis
King et al.
Chest 2007;131:507-516.
ABSTRACT | FULL TEXT  

Racial Differences in 30-Day Mortality for Pulmonary Embolism
Ibrahim et al.
Am. J. Public Health 2006;96:2161-2164.
ABSTRACT | FULL TEXT  

Incidental Pulmonary Emboli in Oncology Patients: Prevalence, CT Evaluation, and Natural History
Gladish et al.
Radiology 2006;240:246-255.
ABSTRACT | FULL TEXT  

Management of Venous Thromboembolism in Patients With Primary and Metastatic Brain Tumors
Gerber et al.
JCO 2006;24:1310-1318.
ABSTRACT | FULL TEXT  

Heart Disease and Stroke Statistics--2006 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Thom et al.
Circulation 2006;113:e85-e151.
FULL TEXT  

Inflow occlusion pulmonary embolectomy in the modern era of cardiac surgery
Bobadilla et al.
J. Thorac. Cardiovasc. Surg. 2006;131:484-486.
FULL TEXT  

Imaging Thromboembolism with Fibrin-Avid 99mTc-Peptide: Evaluation in Swine
Aruva et al.
JNM 2006;47:155-162.
ABSTRACT | FULL TEXT  

Thoracic Ultrasound for Diagnosing Pulmonary Embolism: A Prospective Multicenter Study of 352 Patients
Mathis et al.
Chest 2005;128:1531-1538.
ABSTRACT | FULL TEXT  

Helical CT for the Evaluation of Acute Pulmonary Embolism
Patel and Kazerooni
Am. J. Roentgenol. 2005;185:135-149.
ABSTRACT | FULL TEXT  

Therapeutic Update on the Prevention and Treatment of Venous Thromboembolism
McGuire and Dobesh
Journal of Pharmacy Practice 2004;17:289-307.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.